Evaluation of Effectiveness of Bio-Micro Injection in Treating Alopecia Universalis: A Non-Randomized Interventional Study
DOI:
https://doi.org/10.31661/gmj.v14i.3750Keywords:
Alopecia Areata; Alopecia Universalis; Mesotherapy; JAK InhibitorAbstract
Background: Alopecia areata (AA) is an autoimmune disorder causing non-scarring hair loss, ranging from patchy baldness to total body hair loss. While mesotherapy has shown potential as a localized therapy, its efficacy in AU remains understudied. This study aims to assess the therapeutic impact of mesotherapy in a substantial cohort of 2,000 patients diagnosed with alopecia universalis at Dr. Shirzad Clinic between 2020 and 2024. Methods and Materials: We conducted a non-randomized interventional study on 2,000 alopecia universalis patients across four treatment groups. Participants were divided into four treatment groups: one group received BMI alone, another received a combination of BMI and JAK inhibitors, the third group received only JAK inhibitors, and the fourth group was treated with a combination of BMI, JAK inhibitors, and adalimumab. All of these drugs were administered through mesotherapy techniques. They received the treatment once a month, for a year. Outcomes, including scalp hair regrowth and patient satisfaction, were assessed monthly over a year. Results: A total of 2000 patients participated in this study, with an average age of 26.82 ±1.84 years. Treatment responses varied across groups, with children showing the highest success rates. In Group 1 (BMI only), 20% responded positively. Group 2 (BMI + JAK inhibitors) had a 30% had favorable outcomes. Group 3 (JAK inhibitors only) showed a 34% response rate. The combination treatment in Group 4 resulted in the highest success rate, with 42% of participants responding positively. Conclusion: This study highlights the unique contribution of mesotherapy, particularly when combined with systemic treatments such as BMI, JAK inhibitors, and adalimumab, as an effective and well-tolerated option for alopecia universalis. The large sample size and innovative application of mesotherapy enhance drug delivery, improve treatment outcomes, and reduce systemic side effects, underscoring its potential as a valuable treatment strategy for this challenging condition.
References
Seneschal J, Boniface K, Jacquemin C. Alopecia areata: Recent advances and emerging therapies. Ann Dermatol Venereol. 2022;149(4):222-7.
https://doi.org/10.1016/j.annder.2022.03.006
PMid:35752494
Brzezińska-Wcisło L, Bergler-Czop B, Wcisło-Dziadecka D, Lis-Święty A. New aspects of the treatment of alopecia areata. Postepy Dermatol Alergol. 2014;31(4):262-5.
https://doi.org/10.5114/pdia.2014.40923
PMid:25254012 PMCid:PMC4171667
Liu LY, King BA, Craiglow BG. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review. J Am Acad Dermatol. 2016;75(4):806-12.e3.
https://doi.org/10.1016/j.jaad.2016.04.035
PMid:27436156
MacLean KJ, Tidman MJ. Alopecia areata: more than skin deep. Practitioner. 2013;257(1764):29-32, 3.
Prickitt J, McMichael AJ, Gallagher L, Kalabokes V, Boeck C. Helping patients cope with chronic alopecia areata. Dermatol Nurs. 2004;16(3):237-41.
Grahovac T, Ružić K, Šepić Grahovac D, Dadić Hero E. Depressive disorder and alopecia. Psychiatria Danubina. 2010 Jun 30;22(2):293-5.
Ghanizadeh A. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol. 2008;47(11):1118-20.
https://doi.org/10.1111/j.1365-4632.2008.03743.x
PMid:18986440
Liakopoulou M, Alifieraki T, Katideniou A, Kakourou T, Tselalidou E, Tsiantis J, et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry. 1997;36(5):678-84.
https://doi.org/10.1097/00004583-199705000-00019
PMid:9136503
Aghaei S, Saki N, Daneshmand E, Kardeh B. Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects. ISRN Dermatol. 2014;2014:304370.
https://doi.org/10.1155/2014/304370
PMid:24734190 PMCid:PMC3966411
Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev. 2006;5(1):64-9.
https://doi.org/10.1016/j.autrev.2005.07.001
PMid:16338213
Ito T, Tokura Y. The role of cytokines and chemokines in the T-cell-mediated autoimmune process in alopecia areata. Exp Dermatol. 2014;23(11):787-91.
https://doi.org/10.1111/exd.12489
PMid:25040075
Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20(9):1043-9.
https://doi.org/10.1038/nm.3645
PMid:25129481 PMCid:PMC4362521
Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14(2):81-9.
https://doi.org/10.1016/j.autrev.2014.10.014
PMid:25315746
Norris D. Alopecia areata: current state of knowledge. J Am Acad Dermatol. 2004;51(1 Suppl):S16-7.
https://doi.org/10.1016/j.jaad.2004.01.013
PMid:15243493
Kassira S, Korta DZ, Chapman LW, Dann F. Review of treatment for alopecia totalis and alopecia universalis. Int J Dermatol. 2017;56(8):801-10.
https://doi.org/10.1111/ijd.13612
PMid:28378336
Alkhalifah A. Alopecia areata update. Dermatol Clin. 2013;31(1):93-108.
https://doi.org/10.1016/j.det.2012.08.010
PMid:23159179
Kołcz K, Żychowska M, Sawińska E, Reich A. Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib-A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata. Dermatol Ther (Heidelb). 2023;13(3):843-56.
https://doi.org/10.1007/s13555-023-00889-0
PMid:36639612 PMCid:PMC9984583
Aledani EM, Kaur H, Kasapoglu M, Yadavalli R, Nawaz S, Althwanay A, et al. Mesotherapy as a Promising Alternative to Minoxidil for Androgenetic Alopecia: A Systematic Review. Cureus. 2024;16(5):e59705.
https://doi.org/10.7759/cureus.59705
Cantín M. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects Reviewing the latest version. International Journal of Medical and Surgical Sciences. 2014 Dec 1;1(4):339-46.
https://doi.org/10.32457/ijmss.2014.042
Moon S, Hong J, Go S, Kim BS. Immunomodulation for Tissue Repair and Regeneration. Tissue Eng Regen Med. 2023;20(3):389-409.
https://doi.org/10.1007/s13770-023-00525-0
PMid:36920675 PMCid:PMC10219918
Kushioka J, Chow SK, Toya M, Tsubosaka M, Shen H, Gao Q, et al. Bone regeneration in inflammation with aging and cell-based immunomodulatory therapy. Inflamm Regen. 2023;43(1):29.
https://doi.org/10.1186/s41232-023-00279-1
PMid:37231450 PMCid:PMC10210469
Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004;14(6):364-70.
Philpott MP, Sanders DA, Bowen J, Kealey T. Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. Br J Dermatol. 1996;135(6):942-8.
https://doi.org/10.1046/j.1365-2133.1996.d01-1099.x
PMid:8977716
Arca E, Muşabak U, Akar A, Erbil AH, Taştan HB. Interferon-gamma in alopecia areata. Eur J Dermatol. 2004;14(1):33-6.
Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm. 2010;2010:928030.
https://doi.org/10.1155/2010/928030
PMid:20300578 PMCid:PMC2837895
Liu M, Gao Y, Yuan Y, Yang K, Shen C, Wang J, Tian J. Janus kinase inhibitors for alopecia areata: a systematic review and meta-analysis. JAMA network open. 2023 Jun 1;6(6):e2320351-.
https://doi.org/10.1001/jamanetworkopen.2023.20351
PMid:37368402 PMCid:PMC10300710
King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol. 2023;89(2s):S29-s32.
https://doi.org/10.1016/j.jaad.2023.05.049
PMid:37591562
Shapiro J. Hair loss in women. New England Journal of Medicine. 2007 Oct 18;357(16):1620-30.
https://doi.org/10.1056/NEJMcp072110
PMid:17942874
Aksoy GG. Diffüz saç dökülmeleri; besinsel eksikler ve destekler/Diffuse alopecia; nutritional factors and supplements. Türkderm: Türk Deri Hastalıkları ve Frengi Arşivi= Turkderm: Turkish Archives of Dermatology and Venereology. 2014;48:45.

Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Galen Medical Journal

This work is licensed under a Creative Commons Attribution 4.0 International License.